Healthcare -
Biotechnology - NASDAQ - US
$ 2.895
-1.69 %
$ 2.62 M
Market Cap
-0.03
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Revelation Biosciences, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 7.95 M |
| Operating Income | -7.98 B |
| Other Expenses | -7.96 B |
| Net Income | -15 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 25 K | 40 K | 69.2 K | 0 | 0 |
| Gross Profit | 0 | 25 K | 40 K | 69.2 K | 0 | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 7.9 | 8.7 | 10.9 | 12.0 | 0.1 | 3.64 K |
| Selling, General and Administrative Expenses | 4 426.1 | 4.5 | 5.5 | 5.0 | 0.1 | 3.64 K |
| Research and Development Expenses | 3 549.0 | 4.1 | 5.4 | 6.9 | 2.6 | 0 |
| Operating Income | (7 975.1) | (8.7) | (10.9) | (12.0) | (0.1) | 3.64 K |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (7 063.4) | 8.5 | 35 K | 36.4 K | (1.5) | 2 |
| Pre-Tax Income | (15 038.5) | (0.1) | (10.8) | (12.0) | (1.6) | 3.64 K |
| NET INCOME | ||||||
| Tax Provision | 0 | 0 | 35 K | (0.2) | 3.8 K | (0.2) |
| Net Income | (15 038.5) | (0.1) | (10.8) | (12.0) | (1.6) | 3.64 K |
| EPS | 8.77 K | 0.53 | 601 | 1.28 K | 188 | 0.42 |